The growth of oligonucleotide synthesis market is mainly driven by the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
The global oligonucleotide synthesis market is expected to reach USD 2.46 Billion by 2022 from USD 1.47 Billion in 2017 at a CAGR of 10.9%.
This report segments the market into product, application, end user, and region.
Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. In 2017, synthesized oligonucleotides are estimated to account for the largest share of the total market, followed by reagents. The growth of the synthesized oligonucleotides segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics.
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=200829350
Based on product, the synthesized oligonucleotides market is segmented into primers, probes, large-scale synthesis oligonucleotides, intermediate-scale synthesis oligonucleotides, and linkers & adaptors. Primers are expected to account for the largest share of the synthesized oligonucleotides market in 2017. The intermediate-scale synthesis oligonucleotides segment is projected to register the highest CAGR, due to the rising demand for synthesized oligonucleotides and innovations in manufacturing techniques to produce intermediate-scale oligonucleotides.
Based on end user, the oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The diagnostic laboratories segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the rising diagnostic applications of oligonucleotides and the growing field of molecular diagnostics.
